Research programme: subcutaneous carbapenem - scPharmaceuticals
Alternative Names: scCarbapenemLatest Information Update: 28 Nov 2021
Price :
$50 *
At a glance
- Originator scPharmaceuticals
- Class Antibacterials; Carbapenems
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Gram-negative infections